Rchr
J-GLOBAL ID：202101014963013862
Update date: Apr. 08, 2024
Noura Mina
ノウラ ミナ | Noura Mina
Affiliation and department：
Research field (2)：
Hematology and oncology
, Cell biology
Research theme for competitive and other funds (2)：
- 2023 - 2026 T細胞性急性リンパ性白血病におけるKLF4の機能解明および新規治療法の開発
- 2019 - 2022 Deciphering the regulatory mechanism of autophagy by TXNIP in acute myeloid leukemia (AML)
Papers (16)：
-
Hidemasa Matsuo, Aina Inagami, Yuri Ito, Nana Ito, Shinju Iyoda, Yutarou Harata, Moe Higashitani, Kota Shoji, Miu Tanaka, Mina Noura, et al. Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes. Communications biology. 2024. 7. 1. 123-123
-
Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia. Oncogene. 2023
-
Yukino Kojima, Fumika Kawashima, Takahiko Yasuda, Koya Odaira, Yuichiro Inagaki, Chiharu Yamada, Ami Muraki, Mina Noura, Shuichi Okamoto, Shogo Tamura, et al. EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity. International journal of hematology. 2023. 118. 1. 65-74
-
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, et al. RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells. 2022. 45. 12. 886-895
-
Koya Odaira, Takahiko Yasuda, Kentaro Okada, Takuya Shimooka, Yukino Kojima, Mina Noura, Shogo Tamura, Shingo Kurahashi, Eisuke Iwamoto, Masashi Sanada, et al. Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene. Cancer science. 2022. 114. 3. 781-792
ｍore...
MISC (15)：
-
Mina Noura, Takahiko Yasuda, Shinobu Tsuzuki, Hidemasa Matsuo, Hitoshi Kiyoi, Fumihiko Hayakawa. Suppression of Super-Enhancer-Driven TAL1 Expression By KLF4 in T-Cell Acute Lymphoblastic Leukemia. Blood. 2023. 142. Supplement 1. 1405-1405
-
能浦三奈, 早川文彦. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia. 日本癌学会学術総会抄録集(Web). 2023. 82nd
-
山田千晴, 岡田健太郎, 大平晃也, 村木愛実, 能浦三奈, 岡本修一, 安田貴彦, 都築忍, 早川文彦. ZNF384融合蛋白転写標的の探索. 日本血液学会学術集会抄録(Web). 2023. 85th
-
Kana Nakatani, Hidemasa Matsuo, Yutarou Harata, Moe Higashitani, Asami Koyama, Mina Noura, Yoko Nishinaka-Arai, Yasuhiko Kamikubo, Souichi Adachi. Autophagy Inhibition Enhances CDK4/6 Inhibitor-Induced Apoptosis in t(8;21) Acute Myeloid Leukemia Cells. BLOOD. 2020. 136
-
能浦 三奈, 増谷 弘. レンチウイルスベクターを用いた急性骨髄性白血病(AML)細胞株へのTXNIP遺伝子導入. 天理医療大学紀要. 2020. 8. 1. 47-51
ｍore...
Education (3)：
- 2018 - 2021 京都大学大学院 医学研究科 人間健康科学系専攻 博士後期課程
- 2016 - 2018 京都大学大学院 医学研究科 人間健康科学系専攻 修士課程
- 2012 - 2016 京都大学 医学部 人間健康科学科 検査技術科学専攻
Professional career (1)：
- Doctor (Kyoto University)
Work history (4)：
- 2022/04 - 現在 名古屋大学大学院医学系研究科 助教
- 2021/09 - 2022/03 Shubun University
- 2020/04 - 2021/08 Kyoto University
- 2018/04 - 2020/03 天理医療大学 医療学部臨床検査学科 助手
Return to Previous Page
